Fabentech Biotech Overview
Company Headquarters: Lyon, US
Founded: 2009
Workforce: ~25
Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms
Strategy
Fabentech Biotech is primarily focusing on R&D to develop technology-based solutions for biodefense. Its goal is the rapid development of medical countermeasures against different infectious diseases through its integrated R&D and proprietary manufacturing. Moreover, it is focusing on building collaboration and partnerships with research and academic institutes, investors, and public supporters to enable the rapid production and clinical trials of its biodefense products
